Insiders · Profile

Asanuma Sakae

Director at Werewolf Therapeutics. Filing since 4 May 2021. CIK 0001857822

Company

Date

Role

Action

Shares

Amount

Of holding

HOWL Werewolf Therapeutics, Inc.

4 May 2021

Director

Bought

312,500

$5.00M

17.8%

1 decision on file.